A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia
一项随机、活性对照、多中心、3期临床试验，旨在评估GV1001治疗良性前列腺增生患者的疗效和安全性
期刊:Prostate International
影响因子:2.6
doi:10.1016/j.prnil.2024.10.001
Shin, Teak Jun; Ha, Ji Yong; Kwon, Se Yun; Park, Dong Jin; Kim, Jang Hwan; Lee, Sung Won; Jeong, In Gab; Lee, Ji Youl; Yoo, Tag Keun; Kim, Tae Hyoung; Moon, Du Geon; Hong, Sung Kyu; Cho, Jin Seon; Moon, Hong Sang; Lee, Jeong Woo; Yun, Seok Joong; Jeon, Youn Soo; Park, Jong Gwan; Kang, Taek Won; Moon, Ki Hak; Park, Jae Shin; Hah, Yoon Soo; Kwon, Tae Gyun; Chung, Jae Wook; Chung, Jae Il; Ryu, Dong Soo; Park, Sung Woo; Lee, Kyung Seop
